The undisclosed deal for DiabTec, struck with Jalphur, gives the firm a MENA manufacturing base, as Kelix Bio continues its acquisition spree.
Mubadala-backed Kelix Bio seals MENA insulin manufacturing deal
Leave a comment
Your Trusted Source for Accurate and Timely Updates!
Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Using RSS feeds, we aggregate news from trusted sources to ensure real-time updates on the latest events and trends. Stay ahead with timely, curated information designed to keep you informed and engaged.
